Oncology Institute Inc. (TOI)
1.14
0.03 (2.70%)
At close: Mar 28, 2025, 3:59 PM
1.19
4.14%
After-hours: Mar 28, 2025, 07:58 PM EDT
Company Description
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States.
Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support.
The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services.
It serves adult and senior cancer patients.
The company operates 67 clinic locations.
The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Oncology Institute Inc.
| Country | United States |
| IPO Date | Jun 4, 2020 |
| Industry | Medical - Care Facilities |
| Sector | Healthcare |
| Employees | 700 |
| CEO | Dr. Daniel Virnich FACHE, M.B.A., M.D. |
Contact Details
Address: 18000 Studebaker Road Cerritos, California United States | |
| Website | https://theoncologyinstitute.com |
Stock Details
| Ticker Symbol | TOI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001799191 |
| CUSIP Number | 68236X100 |
| ISIN Number | US68236X1000 |
| Employer ID | 00-0000000 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Dr. Daniel Virnich FACHE, M.B.A., M.D. | Chief Executive Officer & Executive Director |
| Rob Carter | Chief Financial Officer |
| Austin Lee | Vice President of Accounting & Controller |
| Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H. | Chief Medical Officer |
| Jeremy N. Castle M.B.A. | Chief Operations Officer |
| Jordan McInerney | Chief Development Officer |
| Mark Hueppelsheuser Esq. | General Counsel |
| Richard Alan Barasch | Chairman of the Board |
| Stephen Cella | Senior Vice President of Finance |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 27, 2025 | DEFA14A | Filing |
| Mar 27, 2025 | 8-K | Current Report |
| Mar 27, 2025 | DEF 14A | Filing |
| Mar 26, 2025 | ARS | Filing |
| Mar 26, 2025 | 10-K | Annual Report |
| Mar 25, 2025 | 8-K | Current Report |
| Mar 24, 2025 | 8-K | Current Report |
| Mar 24, 2025 | 8-K | Current Report |
| Mar 20, 2025 | 4 | Filing |
| Mar 20, 2025 | 4 | Filing |